BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24468276)

  • 1. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
    Zu X; Liu Y; Wang S; Jin R; Zhou Z; Liu H; Gong R; Xiao G; Wang W
    Antiviral Res; 2014 Apr; 104():7-14. PubMed ID: 24468276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII.
    Li C; Zhang LY; Sun MX; Li PP; Huang L; Wei JC; Yao YL; Isahg H; Chen PY; Mao X
    Antiviral Res; 2012 May; 94(2):179-83. PubMed ID: 22465300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo.
    Li C; Ge LL; Yu YL; Huang L; Wang Y; Sun MX; Ishag H; Ma LX; Li XH; Shen ZQ; Mao X
    Arch Virol; 2014 May; 159(5):1045-55. PubMed ID: 24292966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo.
    Wei J; Hameed M; Wang X; Zhang J; Guo S; Anwar MN; Pang L; Liu K; Li B; Shao D; Qiu Y; Zhong D; Zhou B; Ma Z
    Antiviral Res; 2020 Feb; 174():104673. PubMed ID: 31812636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus.
    Liu H; Liu Y; Wang S; Zhang Y; Zu X; Zhou Z; Zhang B; Xiao G
    J Virol; 2015 May; 89(10):5668-86. PubMed ID: 25762738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.
    Fan J; Liu Y; Xie X; Zhang B; Yuan Z
    Virol Sin; 2013 Jun; 28(3):152-60. PubMed ID: 23709058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells.
    Verma SK; Gupta N; Pattnaik P; Babu JP; Rao PV; Kumar S
    Protein Pept Lett; 2009; 16(11):1334-41. PubMed ID: 20001924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein.
    Chen HL; Her SY; Huang KC; Cheng HT; Wu CW; Wu SC; Cheng JW
    Biopolymers; 2010; 94(3):331-8. PubMed ID: 20069543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
    Chien YJ; Chen WJ; Hsu WL; Chiou SS
    Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5.
    Huang HN; Rajanbabu V; Pan CY; Chan YL; Hui CF; Chen JY; Wu CJ
    Biomaterials; 2011 Oct; 32(28):6804-14. PubMed ID: 21726898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping of a linear epitope on EDIII of Japanese encephalitis virus using a novel neutralizing monoclonal antibody.
    Deng WL; Guan CY; Liu K; Zhang XM; Feng XL; Zhou B; Su XD; Chen PY
    Virus Res; 2014 Jan; 179():133-9. PubMed ID: 24184444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mimotopes of the Japanese encephalitis virus envelope protein using phage-displayed combinatorial peptide library.
    Lin CW; Wu SC
    J Mol Microbiol Biotechnol; 2004; 8(1):34-42. PubMed ID: 15741739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells.
    Nain M; Mukherjee S; Karmakar SP; Paton AW; Paton JC; Abdin MZ; Basu A; Kalia M; Vrati S
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA.
    Yoo JS; Kim CM; Kim JH; Kim JY; Oh JW
    Antiviral Res; 2009 Jun; 82(3):122-33. PubMed ID: 19428603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
    Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
    Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DC-SIGN as an attachment factor mediates Japanese encephalitis virus infection of human dendritic cells via interaction with a single high-mannose residue of viral E glycoprotein.
    Wang P; Hu K; Luo S; Zhang M; Deng X; Li C; Jin W; Hu B; He S; Li M; Du T; Xiao G; Zhang B; Liu Y; Hu Q
    Virology; 2016 Jan; 488():108-19. PubMed ID: 26629951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.
    Chen L; Liu Y; Wang S; Sun J; Wang P; Xin Q; Zhang L; Xiao G; Wang W
    Antiviral Res; 2017 May; 141():140-149. PubMed ID: 28232248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo.
    Shen T; Liu K; Miao D; Cao R; Chen P
    Virology; 2014 Apr; 454-455():48-59. PubMed ID: 24725931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes.
    Liu K; Qian Y; Jung YS; Zhou B; Cao R; Shen T; Shao D; Wei J; Ma Z; Chen P; Zhu H; Qiu Y
    J Virol; 2017 May; 91(10):. PubMed ID: 28250133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.